Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC-Reference-Cited by-同舟云学术

Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC

Published:2019-04-26 Issue:1 Volume:38 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Ciaramella Vincenza,Sasso Ferdinando Carlo,Di Liello Raimondo,Corte Carminia Maria Della,Barra Giusi,Viscardi Giuseppe,Esposito Giovanna,Sparano Francesca,Troiani Teresa,Martinelli Erika,Orditura Michele,De Vita Ferdinando,Ciardiello Fortunato,Morgillo Floriana

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-019-1176-1.pdf

Reference31 articles.

1. Nanjan MJ, Mohammed M, Prashantha Kumar BR, Chandrasekar MJN. Thiazolidinediones as antidiabetic agents: a critical review. Bioorg Chem. 2018. https://doi.org/10.1016/j.bioorg.2018.02.009 .

2. Fan W, Evans R. PPARs and ERRs: molecular mediators of mitochondrial metabolism. CurrOpin Cell Biol. 2015;33:49–54.

3. Tyagi S, Gupta P, Saini AS, Kaushal C, Sharma S. The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases. J Adv Pharm Technol Res. 2011;2:236–40.

4. Fanale D, Amodeo V, Caruso S. The interplay between metabolism, PPAR signaling pathway, and Cancer. PPAR Res. 2017. https://doi.org/10.1155/2017/1830626 .

5. Vitale SG, Lagana AS, Nigro A, La Rosa VL, Rossetti P, Rapisarda AM, et al. Peroxisome proliferator-activated receptor modulationduring metabolic diseases and cancers: master and minions. PPAR Res. 2016. https://doi.org/10.1155/2016/6517313 .

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of N3‐Functionalized TZD‐Indole Conjugates as Potential Anticancer Agents;ChemistrySelect;2024-04-30

2. Effect of Pioglitazone and Cetuximab on Colon Cancer Stem-like Cell (CCSLCs) Properties;Current Stem Cell Research & Therapy;2024-01-31

3. Crocin Ameliorates Diabetic Nephropathy through Regulating Metabolism, CYP4A11/PPARγ, and TGF-β/Smad Pathways in Mice;Current Drug Metabolism;2023-10

4. Quality by design (QbD) abetted development of pioglitazone incorporated liposomes-loaded hyaluronic acid-based in situ hydrogel for the management of melanoma;Journal of Drug Delivery Science and Technology;2023-06

5. Inhibition of PI3K Signaling Intensified the Antileukemic Effects of Pioglitazone: New Insight into the Application of PPARγ Stimulators in Acute Lymphoblastic Leukemia;Indian Journal of Hematology and Blood Transfusion;2023-04-01